Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history. The previous v3.6.5 entry has been removed, updating the version list shown for the study record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry for v3.6.5 has been added to the Study History, accompanying the record's latest version. The previous revision v3.6.4 is removed, indicating an update to the study record version in the history log.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision v3.6.4 was added to the study history, replacing the previous revision v3.6.3, indicating a minor update to the record.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.6.3 appeared in the record history, indicating a site/system update to the page. It does not reflect changes to the study data or eligibility details.SummaryDifference0.1%

- Check79 days agoChange DetectedRecord history shows a new revision tag: Revision: v3.6.2, replacing the earlier Revision: v3.6.0. This appears to be an administrative update to the study record metadata rather than a change to study data or content.SummaryDifference0.1%

- Check94 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants, signaling enrollment has completed. A new record revision (v3.6.0) was added and a previous revision (v3.5.5) was removed, reflecting versioning in the study history.SummaryDifference0.4%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.